Raloxifene
To reduce the risk of breast cancer. Evista is known to be a selective estrogen receptor modulator. When it blocks estrogen receptors in the breast, it has the effect of reducing the risk of breast cancer.

Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.

Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.